BTIS
HZNP

BB&T Investment Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

BB&T Investment Services’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-20
Closed – – 1512
2017
Q3 		$0 Sell
20
-103
-84% -$1.31K ﹤0.01% 1357
2017
Q2 		$1K Buy
123
+103
+515% +$1.28K ﹤0.01% 1114
2017
Q1 		$0 Buy
+20
New +$324 ﹤0.01% 1137

Other funds holding HZNP

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BB&T Investment Services's HZNP Position: Q4 2017 in Review

BB&T Investment Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2017, closing a stake of 20 shares.

BB&T Investment Services first reported a position in HZNP in Q1 2017 and held it in 3 quarters. The position peaked at $1K in Q2 2017. 183 funds tracked by Wall St. Rank hold HZNP as of Q4 2017.

  • BB&T Investment Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • BB&T Investment Services sold 20 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2017.
  • BB&T Investment Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2017 and held it in 3 quarters.
  • BB&T Investment Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1K in Q2 2017.
  • 183 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.